Загрузка...
Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
INTRODUCTION: Clinical trials in Alzheimer's disease are aimed at early stages of disease, including preclinical Alzheimer's disease. The high cost and time required to screen large numbers of participants for Aβ pathology impede the development of novel drugs. This study's objective...
Сохранить в:
| Опубликовано в: : | Alzheimers Dement (Amst) |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045949/ https://ncbi.nlm.nih.gov/pubmed/27722193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2016.07.002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|